Day One Biopharmaceutical Stock (NASDAQ: DAWN) stock price, news, charts, stock research, profile.
Open | $14.800 |
Close | - |
Volume / Avg. | 1.087M / 851.844K |
Day Range | 13.180 - 14.800 |
52 Wk Range | 9.670 - 17.850 |
Market Cap | $1.187B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 42 |
Short Interest | 12.83% |
Days to Cover | 10.83 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Day One Biopharmaceutical (NASDAQ: DAWN) through any online brokerage.
Other companies in Day One Biopharmaceutical’s space includes: Gyre Therapeutics (NASDAQ:GYRE), 4D Molecular Therapeutics (NASDAQ:FDMT), Prothena Corp (NASDAQ:PRTA), Xencor (NASDAQ:XNCR) and Protagonist Therapeutics (NASDAQ:PTGX).
The latest price target for Day One Biopharmaceutical (NASDAQ: DAWN) was reported by Needham on Thursday, April 25, 2024. The analyst firm set a price target for 33.00 expecting DAWN to rise to within 12 months (a possible 142.83% upside). 21 analyst firms have reported ratings in the last year.
The stock price for Day One Biopharmaceutical (NASDAQ: DAWN) is $13.59 last updated Today at April 25, 2024 at 10:14 AM EDT.
There are no upcoming dividends for Day One Biopharmaceutical.
Day One Biopharmaceutical’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Day One Biopharmaceutical.
Day One Biopharmaceutical is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.